Skip to main content
. 2017 Oct 11;8(58):98371–98383. doi: 10.18632/oncotarget.21738

Figure 2. Tumor growth inhibition in U87MG and A673 xenograft models.

Figure 2

Tumor growth inhibition in the A673 rhabdomyosarcoma xenograft model (A, B) and the U87MG glioblastoma model (C, D). Figures 2A and 2C show the anti-tumor response to MP0250, the anti-HGF DARPin® molecule and the anti-VEGF DARPin® molecule. Figure 2B and 2D show a dose response of MP0250. Tumor growth is plotted as mean +/- SEM.